A comparison of different photosensitizing dyes with respect to uptake C3H-tumors and tissues of mice.

Nine dyes, all potential sensitizers for photodynamic cancer therapy (PDT), were injected in mice with C3H mammary carcinomas. Twenty-four hours later the animals were sacrificed and the dye concentrations in tumors and 9 other tissues were measured by means of spectrofluorimetry. The 9 dyes were: Photofrin II (PII), hematoporphyrin (HP)-di-hexyl-ether, PSD-007 (a sensitizer used in clinical trials in China), tetraphenyl porphine tetrasulfonate (TPPS4), tetra(3-hydroxy phenyl)porphyrin (3THPP), aluminium phthalocyanine tetrasulfonate (AlPCTS), aluminium phthalocyanine (AlPC), chlorin e6 (Chl e6) and merocyanine 540 (MC 540). The porphyrin precursor delta-aminolevulinic acid was also tested and found to induce porphyrin fluorescence in tumors and some other tissues. The best tumorlocalizer of those tested was 3THPP. This drug also showed a favorable tissue distribution. The following dyes showed lower skin/tumor concentration ratios than PII (the most widely used dye for PDT): Chl e6, PSD-007, HP-di-hexyl-ether and 3THPP. Low brain/tumor ratios were found for: PSD-007, HP-di-hexyl-ether, 3THPP, TPPS4 and AlPCTS.

[1]  B. C. Wilson,et al.  Studies of HPD and radiolabelled HPD in-vivo and in-vitro. , 1985, Advances in experimental medicine and biology.

[2]  J. Winkelman.  Quantitative studies of tetraphenylporphinesulfonate and hematoporphyrin derivative distribution in animal tumor systems. , 1985, Advances in experimental medicine and biology.

[3]  P. Valk,et al.  The distribution of various water soluble radioactive metalloporphyrins in tumor bearing mice. , 1975, Bioinorganic chemistry.

[4]  J. Moan,et al.  Photodynamic therapy of C3H mouse mammary carcinoma with haematoporphyrin di-ethers as sensitizers. , 1987, British Journal of Cancer.

[5]  J. Moan,et al.  A Chromatographic Study of Hematoporphyrin Derivatives , 1984 .

[6]  J. Winkelman,et al.  The distribution of tetraphenylporphinesulfonate in the tumor-bearing rat. , 1962, Cancer research.

[7]  J. Moan.  PORPHYRIN PHOTOSENSITIZATION AND PHOTOTHERAPY , 1986, Photochemistry and photobiology.

[8]  J. Moan,et al.  Hematoporphyrin ethers--I. Generalized synthesis and chemical properties. , 1987, The International journal of biochemistry.

[9]  T. Dougherty,et al.  Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue. , 1979, Cancer research.

[10]  J. Spikes.  PHTHALOCYANINES AS PHOTOSENSITIZERS IN BIOLOGICAL SYSTEMS AND FOR THE PHOTODYNAMIC THERAPY OF TUMORS , 1986, Photochemistry and photobiology.

[11]  M C Berenbaum,et al.  meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity. , 1986, British Journal of Cancer.

[12]  J. Moan,et al.  Cellular uptake and photosensitizing properties of hematoporphyrin di-ethers with similar chromatographic properties as the tumorlocalizing fraction of hematoporphyrin derivative. , 1987, Cancer letters.

[13]  P. Williamson,et al.  Binding of merocyanine 540 to normal and leukemic erythroid cells , 1980, Cell.

[14]  J. Winkelman,et al.  The concentration in tumor and other tissues of parenterally administered tritium- and 14-C-labeled tetraphenylporphinesulfonate. , 1967, Cancer research.

[15]  C. Gomer,et al.  Photodynamic therapy of intraocular tumors: examination of hematoporphyrin derivative distribution and long-term damage in rabbit ocular tissue. , 1985, Cancer research.